Tranquis Therapeutics
Latest round
- Series A
Last raised
- Jul 2020
Total raised
- $30M
Investors
- 5
About Tranquis Therapeutics
Tranquis Therapeutics, Inc.Tranquis Therapeutics, Inc. was founded in 2016 and is headquartered in San Mateo, US. The company is dedicated to creating novel therapeutic options for mental health and neurodegenerative conditions.Tranquis Therapeutics, Inc. specializes in developing biologically-based treatments aimed at improving mental health and addressing neurodegenerative conditions. The company aims to expand its research and development efforts, with plans to enter new markets in North America and Europe by 2023.
Who invested in Tranquis Therapeutics
5 investors across 1 round
See all investors in Tranquis Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 9, 2020
Amount
$30M
Investors
Questions about Tranquis Therapeutics
Who invested in Tranquis Therapeutics?
Tranquis Therapeutics has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tranquis Therapeutics raised?
Tranquis Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Tranquis Therapeutics last raise money?
Tranquis Therapeutics's most recent round on record is a Series A, in Jul 2020.
What does Tranquis Therapeutics do?
Tranquis Therapeutics is a biotechnology company.
Where is Tranquis Therapeutics headquartered?
Tranquis Therapeutics is headquartered in San Mateo, US.
Which VCs invest in companies like Tranquis Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Tranquis Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Tranquis Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.